(S)-Cloperastine Fendizoate (Levocloperastine Fendizoate)
- CAS
- 220329-19-1
- Formula
- C40H38ClNO5
- MW
- 648.2 g/mol
VQ-031522
(S)-ethyl 3-((1-hydroxypropan-2-yl)amino)-2-(2,3,4-trifluorobenzoyl)acrylate
- CAS
- 601490-35-1
- Formula
- C15H16F3NO4
- MW
- 331.29 g/mol
In stock
(S)-Ethyl 3-[2-(dimethylamino)ethyl]-5-[(2-oxooxazolidin-4-yl)methyl]-1H-indole-2-carboxylate
- CAS
- 191864-24-1
- Formula
- C19H25N3O4
- MW
- 359.4 g/mol
VQ-028791
(S)-Ethyl 4-(3-chloro-4-methoxybenzylamino)-2-(2-(hydroxymethyl)pyrrolidin-1-yl)pyrimidine-5-carboxylate
- CAS
- 330785-83-6
- Formula
- C20H25ClN4O4
- MW
- 420.9 g/mol
VQ-043872
(S)-Methyl 2-amino-2-(4-hydroxyphenyl)acetatehydrochloride
- CAS
- 127369-30-6
- Formula
- C9H12ClNO3
- MW
- 217.65 g/mol
VQ-029144
(S)-Methyl 2-amino-2-phenylacetate hydrochloride
- CAS
- 15028-39-4
- Formula
- C9H12ClNO2
- MW
- 201.65 g/mol
VQ-036407
(S)-Methyl 5-methoxy-3,4-dihydro-2H-pyrrole-2-carboxylate
- CAS
- 173142-47-7
- Formula
- C7H11NO3
- MW
- 157.17 g/mol
VQ-028688
(S)-N-((3-(4-Acetamidophenyl)-2-oxooxazolidin-5-yl)methyl)-5-chlorothiophene-2-carboxamide
- CAS
- 2422046-61-3
- Formula
- C17H16ClN3O4S
- MW
- 393.8 g/mol
VQ-027857
(S)-N-((R)-1-(Naphthalen-1-yl)ethyl)-2-(3-(trifluoromethyl)phenyl)propan-1-amine
- CAS
- 2059891-96-0
- Formula
- C22H22F3N
- MW
- 357.4 g/mol
VQ-024979
(S)-N-((S)-1-(((2S,4S)-1-Chloro-2-hydroxy-2,6-dimethyl-3-oxoheptan-4-yl)amino)-1-oxo-3-phenylpropan-2-yl)-4-methyl-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido)pentanamide
- CAS
- 1541171-67-8
- Formula
- C40H58ClN5O7
- MW
- 756.4 g/mol
VQ-022013
(S)-N-((S)-1-Amino-1-oxobutan-2-yl)-2-((R)-2-oxo-4-propylpyrrolidin-1-yl)butanamide
- CAS
- 2432911-32-3
- Formula
- C15H27N3O3
- MW
- 297.39 g/mol
VQ-035392
(S)-N-((S)-1-Amino-1-oxobutan-2-yl)-3-(chloromethyl)hexanamide
- CAS
- 2052297-74-0
- Formula
- C11H21ClN2O2
- MW
- 248.75 g/mol
VQ-036029
(S)-N-(1-(3-(2-Cyanobenzyl)-1-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)piperidin-3-yl)benzamide
- CAS
- 1618644-32-8
- Formula
- C25H25N5O3
- MW
- 443.5 g/mol
VQ-024207
(S)-N-(1-(3-Methylbutanamido)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxamide
- CAS
- 862894-96-0
- Formula
- C19H22N4O3
- MW
- 354.4 g/mol
VQ-021861
(S)-N-(1-Amino-1-oxobutan-2-yl)-4-hydroxybutanamide
- CAS
- 1868118-63-1
- Formula
- C8H16N2O3
- MW
- 188.22 g/mol
VQ-031510
(S)-N-(1-Amino-1-oxopropan-2-yl)-4-((3-fluorobenzyl)oxy)benzamide
- CAS
- 2268802-59-9
- Formula
- C17H17FN2O3
- MW
- 316.33 g/mol
VQ-027971
(S)-N-(2-(1-(3-Ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl)-1,3-dioxoisoindolin-5-yl)acetamide
- CAS
- 2201974-01-6
- Formula
- C22H24N2O7S
- MW
- 460.5 g/mol
VQ-029197
(S)-N-(2-(1-(3-Ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl)-5-hydroxy-1,3-dioxoisoindolin-4-yl)acetamide
- CAS
- 2096492-43-0
- Formula
- C22H24N2O8S
- MW
- 476.5 g/mol
VQ-029199
(S)-N-(2-(1,6,7,8-Tetrahydro-2H-indeno[5,4-b]furan-8-yl)ethyl)acetamide
- CAS
- 326793-94-6
- Formula
- C15H19NO2
- MW
- 245.32 g/mol
VQ-027734
(S)-N-(2-(7,8-Dihydro-6H-indeno[5,4-b]furan-8-yl)ethyl)propionamide
- CAS
- 880152-62-5
- Formula
- C16H19NO2
- MW
- 257.33 g/mol
VQ-027739
(S)-N-(3-((3-Fluoro-4-morpholinophenyl)amino)-2-hydroxypropyl)acetamide
- CAS
- 1561176-27-9
- Formula
- C15H22FN3O3
- MW
- 311.35 g/mol
VQ-031587
(S)-N-(3-Chloro-4-fluorophenyl)-6-nitro-7-(tetrahydrofuran-3-yloxy)quinazolin-4-amine
- CAS
- 314771-88-5
- Formula
- C18H14ClFN4O4
- MW
- 404.8 g/mol
VQ-020751
(S)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-(((R)-tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dimethylamino)-3-hydroxybutanamide
- CAS
- 2413212-21-0
- Formula
- C24H27ClFN5O4
- MW
- 503.95 g/mol
VQ-024154
(S)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)but-3-enamide
- CAS
- 2413212-17-4
- Formula
- C22H20ClFN4O3
- MW
- 442.87 g/mol
VQ-020746
(S)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)formamide
- CAS
- 2223677-60-7
- Formula
- C19H16ClFN4O3
- MW
- 402.8 g/mol
VQ-020752
(S)-N-(4-Chloro-2-(4-cyclopropyl-1,1,1-trifluoro-2-hydroxybut-3-yn-2-yl)phenyl)-4-methoxybenzamide
- CAS
- 353270-77-6
- Formula
- C21H17ClF3NO3
- MW
- 423.8 g/mol
VQ-030390
(S)-N-(5-Chloropyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide
- CAS
- 2226370-52-9
- Formula
- C11H12ClN5O2
- MW
- 281.7 g/mol
VQ-026372
(S)-N-[[3-(3-Fluoro-4-(4-morpholinyl)phenyl)-2-oxo-5-oxazolidinyl]methyl]benzylamine hydrochloride
- CAS
- 1236077-63-6
- Formula
- C21H25ClFN3O3
- MW
- 421.9 g/mol
VQ-038070
(S)-N-[1-(3-Hydroxy-3-methylbutanamido)-1-oxo-3-phenylpropan-2-yl]pyrazine-2-carboxamide
- CAS
- 2379402-85-2
- Formula
- C19H22N4O4
- MW
- 370.4 g/mol
VQ-024616
(S)-N-[4-[3-[(1,1-Dimethylethyl)amino]-2-hydroxypropoxy]-1,2,5-thiadiazol-3-yl]-N-(2-hydroxyethyl)-glycine
- CAS
- 75014-25-4
- Formula
- C13H24N4O5S
- MW
- 348.42 g/mol
VQ-042555
(S)-N-Boc-3-hydroxyadamantylglycine-L-cis-4,5-methanoprolinamide
- CAS
- 361442-01-5
- Formula
- C23H35N3O5
- MW
- 433.5 g/mol
VQ-033778
(S)-N2,N2,6-Trimethyl-1,6-dihydro-1,3,5-triazine-2,4-diamine Hydrochloride (1:x)
- CAS
- 775351-62-7
- Formula
- C6H13N5 + (HCl)x
VQ-037674
(S)-N4-(3-Chloro-4-fluorophenyl)-7-((tetrahydrofuran-3-yl)oxy) quinazoline-4,6-diamine
- CAS
- 314771-76-1
- Formula
- C18H16ClFN4O2
- MW
- 374.8 g/mol
VQ-020748
(S)-N4-(3-chlorophenyl)-7-((tetrahydrofuran-3-yl)oxy)quinazoline-4,6-diamine
- CAS
- 2413212-09-4
- Formula
- C18H17ClN4O2
- MW
- 356.8 g/mol
VQ-021445
(S)-N4-(3,4-Difluorophenyl)-7-((tetrahydrofuran-3-yl)oxy)quinazoline-4,6-diamine
- CAS
- 2044709-72-8
- Formula
- C18H16F2N4O2
- MW
- 358.3 g/mol
VQ-028905
(S)-N4-(4-Fluorophenyl)-7-((tetrahydrofuran-3-yl)oxy)quinazoline-4,6-diamine
- CAS
- 2413212-07-2
- Formula
- C18H17FN4O2
- MW
- 340.4 g/mol
VQ-028797
(S)-N4-phenyl-7-((tetrahydrofuran-3-yl)oxy)quinazoline-4,6-diamine
- CAS
- 2413212-08-3
- Formula
- C18H18N4O2
- MW
- 322.36 g/mol
VQ-034773
(S)-N6,N6-dipropyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine
- CAS
- 1147937-31-2
- Formula
- C8H10N4O3S
- MW
- 242.26 g/mol
VQ-027566